Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Neil Woodford’s New Portfolio – In Full!

| G A Chester

AstraZeneca plc (LON:AZN), GlaxoSmithKline plc (LON:GSK), Imperial Tobacco Group PLC (LON:IMT), HSBC Holdings plc (LON:HSBA) and British American Tobacco Plc…

Read more »

Investing Articles

Is It Time To Sell AstraZeneca plc?

| Kevin Godbold

Growth seems distant and AstraZeneca plc (LON:AZN) shares are expensive...

Read more »

Investing Articles

5 Shares To Protect Your Portfolio From A Market Meltdown: National Grid plc, United Utilities Group PLC, GlaxoSmithKline plc, British Sky Broadcasting Group plc And AstraZeneca plc

| Rupert Hargreaves

National Grid plc (LON: NG), United Utilities Group PLC (LON: UU), GlaxoSmithKline plc (LON: GSK), British Sky Broadcasting Group plc…

Read more »

Investing Articles

Which Bid Target Should You Buy: Shire PLC Or AstraZeneca plc?

| Peter Stephens

With Shire PLC (LON: SHP) and AstraZeneca plc (LON: AZN) both apparent bid targets, which one has the most potential?

Read more »

Investing Articles

1.5 Reasons Why AstraZeneca plc Is A Perilous Income Pick

| Royston Wild

Royston Wild looks at why AstraZeneca plc (LON: AZN) is a hazardous investment choice.

Read more »

Investing Articles

Neil Woodford Still Loves Astrazeneca plc And GlaxoSmithKline plc

| Harvey Jones

Neil Woodford's passion for AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) is undiminished. Should you share the love?

Read more »

Investing Articles

3 Reasons Why You Should Sell Shire PLC

| Roland Head

Shire PLC (LON:SHP) shareholders should heed the lessons of Pfizer's bid for AstraZeneca plc (LON:AZN), says Roland Head.

Read more »

Investing Articles

3 Growth Shares For Your Nisa: AstraZeneca plc, Diageo plc And Unilever plc

| Rupert Hargreaves

AstraZeneca plc (LON:AZN), Diageo plc (LON:DGE) and Unilever plc (LON:ULVR) look to be three great growth picks for your new…

Read more »

Investing Articles

Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And AstraZeneca plc?

| Peter Stephens

Is Shire PLC (LON: SHP) now a better investment than GlaxoSmithKline plc (LON: GSK) and AstraZeneca plc (LON: AZN)?

Read more »

Investing Articles

Is AstraZeneca plc’s Latest Director Deal A Game-Changer?

| Peter Stephens

With AstraZeneca plc (LON:AZN)'s CEO buying shares this week, is it a significant event for investors?

Read more »

Investing Articles

Why Shire PLC Could Be A Winning Stock!

| Peter Stephens

Pharmaceutical company Shire PLC (LON: SHP) could be worth buying — here’s why.

Read more »

Investing Articles

One Reason Why I Would Buy AstraZeneca plc Today

| Royston Wild

Royston Wild explains why AstraZeneca plc (LON: AZN) could become a high-profile acquisition target once again.

Read more »